Pfizer Inc
- SEC CIK
- 0000078003
No open-market purchases or sales filed in the past year.
Current role at each company
- CERE Cerevel Therapeutics Holdings, Inc.Other: Former 10% Owneras of Aug 5, 2024
- PYXS Pyxis Oncology, Inc.10% Owneras of Mar 23, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Pfizer Inc as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
PYXS Pyxis Oncology, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 23, 2023 (view filing)4:14 PM ET | Mar 17 | 6 days | Pfizer Inc and 1 other10% Owner | PPurchaseCommon Stock, $0.001 par value per share | +1.81M | $2.76 | +$5.00M | +43.8%5.95M after | Amended |